TMBCZG
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TMBCZG, covering 2021-03-02 to 2021-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia [Phase 2]